Cost Isn’t the Only Reason Medicare Doesn’t Cover Wegovy
January 9, 2024

(STAT News) – The origin of federal restrictions of anti-obesity medications has nothing to do with these current cost-benefit considerations, however: The Medicare and Medicaid policies are three-decade-old restrictions on weight-loss medication in general — a legislative legacy reflecting a different cultural and clinical understanding of obesity. (Read More)